RIDGEWOOD, N.J., September 20, 2016 — The Valley Hospital has received a full, four-year accreditation from the American Society for Radiation Oncology’s (ASTRO) Accreditation Program for Excellence (APEx®). Valley’s cancer program holds the distinction of being the only one in New Jersey, and 1 of 7 in the country, to receive this accreditation.
APEx is an independent radiation oncology practice accreditation program based on 16 evidence-based standards of radiation oncology practice. These 16 standards are focused on five pillars of patient care: the process of care; the radiation oncology team; safety; quality management; and patient-centered care.
Accreditation through APEx is a rigorous, voluntary, multi-step process that can take up to one year to complete. To receive accreditation, Valley’s policies and procedures were reviewed using objective, verifiable expectations for performance in radiation oncology. Valley also demonstrated its commitment to high standards of safety, quality and patient-centered care through effective communication, coordinated treatment and engaging patients and their families as partners in care.
“We are pleased to receive APEx accreditation from ASTRO, the premier radiation oncology society in the world,” said Chad DeYoung, M.D., Co-Director of Radiation Oncology at Valley. “Evaluating our processes in relation to ASTRO’s high standards, including standards for safety and quality, validates our practices and recognizes the efforts of our radiation oncology team to deliver patient-centered radiation oncology care.”
“ASTRO is proud to recognize Valley for achieving APEx accreditation,” said ASTRO chair Bruce D. Minsky, M.D., FASTRO. “Valley has demonstrated a commitment to providing their patients with safe, high-quality radiation therapy services.”
Valley’s oncology program, which recently partnered with Mount Sinai Health System, provides comprehensive, patient-centered cancer care in northern New Jersey. Valley offers state-of-the-art treatment options for oncology patients, including advanced diagnostic technology, minimally invasive surgery, chemotherapy, immunotherapy, targeted therapies and radiation oncology, as well as a robust program of inpatient and outpatient supportive services, clinical trials and access to Mount Sinai’s renowned experts in the field of cancer care. For more information, visit www.valleyhealthcancercenter.com.Photo Caption: The Valley Hospital’s Radiation Oncologists: (l-r) Co-Director Michael Wesson, M.D., Thomas Kole, M.D., Ph.D., and Co-Director Chad DeYoung, M.D.